3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
2
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
11
Gastrointestinal
10
Endocrine
6
Breast
6
Lymphoid
3
Genitourinary
3
Thoracic
2
Other hematologic neoplasm
2
Gynecologic
2
Classical hematology
2
Plasma cell
1
Other solid neoplasm
1
Myeloid
1
Head & Neck
1
Dermatologic
1
Conditions
Melanoma
1486
Lymphoma, T-Cell, Cutaneous
313
Skin Neoplasms
267
Keratosis, Actinic
249
Mycosis Fungoides
224
Sezary Syndrome
216
Lymphoma, Non-Hodgkin
206
Leukemia, Lymphocytic, Chronic, B-Cell
200
Lymphoma, Large B-Cell, Diffuse
198
Lymphoma, Follicular
196
Neoplasms
194
Precursor Cell Lymphoblastic Leukemia-Lymphoma
192
Lymphoma, B-Cell, Marginal Zone
192
Lymphoma, Mantle-Cell
191
Hodgkin Disease
191
Carcinoma, Basal Cell
190
Breast Neoplasms
185
Burkitt Lymphoma
184
Lymphoma
182
Lymphoma, Large-Cell, Immunoblastic
177
Carcinoma, Non-Small-Cell Lung
150
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
140
Lymphoma, Large-Cell, Anaplastic
137
Multiple Myeloma
133
Carcinoma, Renal Cell
128
Immunoblastic Lymphadenopathy
126
Uveal Melanoma
125
Neoplasm Metastasis
120
Leukemia, Myeloid, Acute
113
Waldenstrom Macroglobulinemia
103
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Diabetes Mellitus, Type 2
×
Dermatologic
×
Clear all
NCT04726319
2026-05-06
FHAMe
University of Toronto
Phase NA
Completed
627 enrolled